Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market
June 27 2024 - 11:11AM
The Akkermansia Company, creator of clinically proven,
next-generation gut health solutions, is pleased to announce its
launch into the U.S. consumer market. The company’s founders were
the first to discover and decode Akkermansia muciniphila, the
bacterium responsible for protecting the gut barrier to support
optimal health and longevity.
Akkermansia muciniphila exists naturally in a healthy gut, but
many people have low levels, which can lead to a leaky gut and
inflammation, linked to obesity, diabetes, cardiovascular disease,
and other health challenges.
To solve this problem, The Akkermansia Company has developed
dietary supplements with science-backed ingredients that replenish
low levels of Akkermansia muciniphila and protect and restore the
gut barrier.
The supplements were many years of research in the making. In
2004, Professor Willem M. de Vos, co-founder of The
Akkermansia Company, and his team at Wageningen University were the
first to discover Akkermansia muciniphila.
Under the guidance of Professor de Vos, Dr. Muriel Derrien, a
PhD student, successfully isolated and characterized Akkermansia
muciniphila, and the team named the strain in honor of Dr.
Anton Akkermans, a famous microbial ecologist working in their
Wageningen lab.
Professor de Vos’s team then developed pasteurized Akkermansia
muciniphila MucT™, the only strain of Akkermansia that has been
clinically studied in humans.
A 2019 study in human volunteers showed that daily
administration of pasteurized Akkermansia muciniphila MucT™ for
three months is safe and effectively improves gut barrier
function. This postbiotic provides superior stability and
contains up to 100 times more bioavailable Akkermansia muciniphila
than probiotic products on the market.
“After many years of research and human clinical trials, we have
created the most bio-efficacious form of Akkermansia muciniphila,”
said Professor de Vos. “Our proprietary pasteurized strain,
Akkermansia muciniphila MucT™, is a safe, clinically proven
breakthrough in gut and microbiome health. It is carefully designed
to support optimal health and longevity and proven to work. Further
clinical data will be released later this year.”
The Akkermansia Company’s first supplement available in the U.S.
— Healthy Weight — contains pasteurized Akkermansia muciniphila
MucT™ to strengthen the gut barrier, paired with EGCG Green Tea and
Chromium to promote weight management and support longevity and
vitality.
Healthy Weight has been available in Europe since 2021. It now
retails for $59.99 for a 30-day supply on Amazon.
To learn more about The Akkermansia Company, visit
theakkermansiacompany.com.
About The Akkermansia Company An international
leader in developing next-generation probiotic and postbiotic
supplements, The Akkermansia Company is on a mission to shift the
focus of the microbiome health paradigm from symptoms to root
cause. Founded by Professor Willem M. de Vos and his team, the
company discovered, named, patented, and developed Akkermansia
muciniphila MucT™, which plays a major role in helping to maintain
a healthy gut microbiome. After becoming available in Europe in
2021, the company’s first supplement is now available in the U.S.
on Amazon, as well as through the health care practitioner channel.
Learn more at theakkermansiacompany.com and follow The Akkermansia
Company on Facebook and Instagram.
MEDIA CONTACT: Lisa Lazarczyk, LAZ PRTel:
617.838.7327 or lisa@lazpr.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/a021479e-4d8d-4299-843d-6d8e8d4e2caf